Risk factors associated with incident cataracts and cataract surgery in the age-related eye disease study (AREDS): AREDS report number 32

Ophthalmology

Volumn 118, Issue 11, 2011, Pages 2113-2119

  Chang, Jessica R ^a   Koo, Euna ^a   Agrón, Elvira ^a   Hallak, Joelle ^b   Clemons, Traci ^c   Azar, Dimitri ^b   Sperduto, Robert D ^c   Ferris III, Frederick L ^a   Chew, Emily Y ^a  

^a NATIONAL EYE INSTITUTE   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c EMMES CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; NONSTEROID ANTIINFLAMMATORY AGENT; THYROID HORMONE; VITAMIN;

ADULT; AGED; AGING; ARTICLE; CATARACT; CATARACT EXTRACTION; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG USE; EDUCATIONAL STATUS; ESTROGEN THERAPY; FEMALE; FOLLOW UP; HUMAN; HYPERMETROPIA; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE; REFRACTION ERROR; RISK FACTOR; SEX DIFFERENCE; SMOKING; SUBCAPSULAR CATARACT; WEIGHT CHANGE;

AGED; AGED, 80 AND OVER; AGING; ANTIOXIDANTS; CATARACT; CATARACT EXTRACTION; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MACULAR DEGENERATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; TRACE ELEMENTS; VISUAL ACUITY; VITAMINS;

EID: 80255131252     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2011.03.032     Document Type: Article

References (64)

1. D. Pascolini, S.P. Mariotti, and G.P. Pokharel 2002 global update of available data on visual impairment: a compilation of population-based prevalence studies Ophthalmic Epidemiol 11 2004 67 115
2. World Health Organization Visual Impairment and Blindness: Fact Sheet N282 May 2009 http://www.who.int/mediacentre/factsheets/fs282/en/ Accessed January 1, 2010
3. N. Congdon, B. O'Colmain, and C.C. Klaver Causes and prevalence of visual impairment among adults in the United States Arch Ophthalmol 122 2004 477 485
4. M. Salm, D. Belsky, and F.A. Sloan Trends in cost of major eye diseases to Medicare, 1991 to 2000 Am J Ophthalmol 142 2006 976 982
5. N. Congdon, J.R. Vingerling, and B.E. Klein Prevalence of cataract and pseudophakia/aphakia among adults in the United States Arch Ophthalmol 122 2004 487 494
6. R. Hiller, R.D. Sperduto, and F. Ederer Epidemiologic associations with nuclear, cortical, and posterior subcapsular cataracts Am J Epidemiol 124 1986 916 925
7. R. Klein, B.E. Klein, and S.C. Jensen The relation of socioeconomic factors to age-related cataract, maculopathy, and impaired vision The Beaver Dam Eye Study Ophthalmology 101 1994 1969 1979
8. R. Hiller, R.D. Sperduto, and M.J. Podgor Cigarette smoking and the risk of development of lens opacities The Framingham studies Arch Ophthalmol 115 1997 1113 1118
9. A. Hennis, S.Y. Wu, B. Nemesure, and M.C. Leske Risk factors for incident cortical and posterior subcapsular lens opacities in the Barbados Eye Studies Arch Ophthalmol 122 2004 525 530
10. B.E. Klein, R. Klein, and K.E. Lee Diabetes, cardiovascular disease, selected cardiovascular disease risk factors, and the 5-year incidence of age-related cataract and progression of lens opacities: the Beaver Dam Eye Study Am J Ophthalmol 126 1998 782 790
11. T.W. Bochow, S.K. West, and A. Azar Ultraviolet light exposure and risk of posterior subcapsular cataracts Arch Ophthalmol 107 1989 369 372
12. K.J. Cruickshanks, B.E. Klein, and R. Klein Ultraviolet light exposure and lens opacities: the Beaver Dam Eye Study Am J Public Health 82 1992 1658 1662
13. S.K. West, D.D. Duncan, and B. Munoz Sunlight exposure and risk of lens opacities in a population-based study: the Salisbury Eye Evaluation project JAMA 280 1998 714 718
14. L.E. Caulfield, S.K. West, Y. Barron, and J. Cid-Ruzafa Anthropometric status and cataract: the Salisbury Eye Evaluation project Am J Clin Nutr 69 1999 237 242
15. R.J. Glynn, W.G. Christen, and J.E. Manson Body mass index An independent predictor of cataract Arch Ophthalmol 113 1995 1131 1137
16. R. Hiller, M.J. Podgor, and R.D. Sperduto A longitudinal study of body mass index and lens opacities The Framingham Studies Ophthalmology 105 1998 1244 1250
17. R.G. Cumming, P. Mitchell, and S.R. Leeder Use of inhaled corticosteroids and the risk of cataracts N Engl J Med 337 1997 8 14
18. B.E. Klein, R. Klein, K.E. Lee, and L.G. Danforth Drug use and five-year incidence of age-related cataracts: The Beaver Dam Eye Study Ophthalmology 108 2001 1670 1674
19. J.J. Wang, E. Rochtchina, and A.G. Tan Use of inhaled and oral corticosteroids and the long-term risk of cataract Ophthalmology 116 2009 652 657
20. J.M. Benitez del Castillo, T. del Rio, and J. Garcia-Sanchez Effects of estrogen use on lens transmittance in postmenopausal women Ophthalmology 104 1997 970 973
21. G.L. Kanthan, J.J. Wang, and G. Burlutsky Exogenous oestrogen exposure, female reproductive factors and the long-term incidence of cataract: the Blue Mountains Eye Study Acta Ophthalmol 88 2009 773 778
22. B.E. Klein, R. Klein, and L.L. Ritter Is there evidence of an estrogen effect on age-related lens opacities? The Beaver Dam Eye Study Arch Ophthalmol 112 1994 85 91
23. Age-Related Eye Disease Study Research Group The age-related eye disease study (AREDS) system for classifying cataracts from photographs: AREDS report no. 4 Am J Ophthalmol 131 2001 167 175
24. Age-Related Eye Disease Study Research Group The Age-Related Eye Disease Study (AREDS): design implications AREDS report no. 1 Control Clin Trials 20 1999 573 600
25. Age-Related Eye Disease Study Research Group Risk factors associated with age-related nuclear and cortical cataract: a case-control study in the Age-Related Eye Disease Study, AREDS report no. 5 Ophthalmology 108 2001 1400 1408
26. D. Cox Regression models and life-tables (with discussion) J R Stat Soc 34 1972 187 220
27. L. Wei, D. Lin, and L. Weissfeld Regression analysis of multivariate incomplete failure time data by modeling marginal distributions J Am Stat Assoc 84 1989 1065 1073
28. D. Collett Strategy for model selection D. Collett, Modelling Survival Data in Medical Research 2nd ed 1994 Chapman & Hall Boca Raton, FL 78 86
29. G.L. Kanthan, J.J. Wang, and E. Rochtchina Ten-year incidence of age-related cataract and cataract surgery in an older Australian population The Blue Mountains Eye Study Ophthalmology 115 2008 80814.e1
30. B.E. Klein, R. Klein, and K.E. Lee Incidence of age-related cataract over a 10-year interval: the Beaver Dam Eye Study Ophthalmology 109 2002 2052 2057
31. M.C. Leske, L.T. Chylack Jr, and Q. He Risk factors for nuclear opalescence in a longitudinal study LSC Group. Longitudinal Study of Cataract Am J Epidemiol 147 1998 36 41
32. B.E. Klein, R. Klein, K.E. Lee, and R.E. Gangnon Incidence of age-related cataract over a 15-year interval the Beaver Dam Eye Study Ophthalmology 115 2008 477 482
33. M.C. Leske, S.Y. Wu, and B. Nemesure Nine-year incidence of lens opacities in the Barbados Eye Studies Ophthalmology 111 2004 483 490
34. C.A. McCarty, B.N. Mukesh, C.L. Fu, and H.R. Taylor The epidemiology of cataract in Australia Am J Ophthalmol 128 1999 446 465
35. S.K. West, B. Munoz, and O.D. Schein Racial differences in lens opacities: the Salisbury Eye Evaluation (SEE) project Am J Epidemiol 148 1998 1033 1039
36. D.S. Friedman, S.K. West, and B. Munoz Racial variations in causes of vision loss in nursing homes: The Salisbury Eye Evaluation in Nursing Home Groups (SEEING) Study Arch Ophthalmol 122 2004 1019 1024
37. B. Rahmani, J.M. Tielsch, and J. Katz The cause-specific prevalence of visual impairment in an urban population The Baltimore Eye Survey Ophthalmology 103 1996 1721 1726
38. M.C. Leske, S.Y. Wu, and A.M. Connell Lens opacities, demographic factors and nutritional supplements in the Barbados Eye Study Int J Epidemiol 26 1997 1314 1322
39. S.K. West, and C.T. Valmadrid Epidemiology of risk factors for age-related cataract Surv Ophthalmol 39 1995 323 334
40. The Italian-American Cataract Study Group Risk factors for age-related cortical, nuclear, and posterior subcapsular cataracts Am J Epidemiol 133 1991 541 553
41. M.C. Leske, L.T. Chylack Jr, and S.Y. Wu The Lens Opacities Case-Control Study Risk factors for cataract Arch Ophthalmol 109 1991 244 251
42. C. Delcourt, J.P. Cristol, and F. Tessier Risk factors for cortical, nuclear, and posterior subcapsular cataracts: the POLA study Pathologies Oculaires Liees a l'Age Am J Epidemiol 151 2000 497 504
43. W.G. Christen, J.E. Manson, and J.M. Seddon A prospective study of cigarette smoking and risk of cataract in men JAMA 268 1992 989 993
44. M.C. Leske, S.Y. Wu, and A. Hennis Diabetes, hypertension, and central obesity as cataract risk factors in a black population The Barbados Eye Study Ophthalmology 106 1999 35 41
45. J.S. Tan, J.J. Wang, and P. Mitchell Influence of diabetes and cardiovascular disease on the long-term incidence of cataract: the Blue Mountains Eye Study Ophthalmic Epidemiol 15 2008 317 327
46. M.A. Chang, N.G. Congdon, and I. Bykhovskaya The association between myopia and various subtypes of lens opacity: SEE (Salisbury Eye Evaluation) project Ophthalmology 112 2005 1395 1401
47. T.Y. Wong, B.E. Klein, and R. Klein Refractive errors and incident cataracts: the Beaver Dam Eye Study Invest Ophthalmol Vis Sci 42 2001 1449 1454
48. C. Younan, P. Mitchell, and R.G. Cumming Myopia and incident cataract and cataract surgery: the Blue Mountains Eye Study Invest Ophthalmol Vis Sci 43 2002 3625 3632
49. M. Kuzniarz, P. Mitchell, R.G. Cumming, and V.M. Flood Use of vitamin supplements and cataract: the Blue Mountains Eye Study Am J Ophthalmol 132 2001 19 26
50. M.C. Leske, L.T. Chylack Jr, and Q. He Antioxidant vitamins and nuclear opacities: the longitudinal study of cataract Ophthalmology 105 1998 831 836
51. J.M. Seddon, W.G. Christen, and J.E. Manson The use of vitamin supplements and the risk of cataract among US male physicians Am J Public Health 84 1994 788 792
52. G. Maraini, R.D. Sperduto, and F. Ferris A randomized, double-masked, placebo-controlled clinical trial of multivitamin supplementation for age-related lens opacities Clinical trial of nutritional supplements and age-related cataract report no. 3 Ophthalmology 115 2008 599 607.e1
53. R.D. Sperduto, T.S. Hu, and R.C. Milton The Linxian cataract studies Two nutrition intervention trials Arch Ophthalmol 111 1993 1246 1253
54. R.C. Milton, R.D. Sperduto, T.E. Clemons, and F.L. Ferris III Centrum use and progression of age-related cataract in the Age-Related Eye Disease Study: a propensity score approach AREDS report no. 21 Ophthalmology 113 2006 1264 1270
55. R. van Heyningen, and J.J. Harding Do aspirin-like analgesics protect against cataract? A case-control study Lancet 1 1986 1111 1113
56. J.J. Harding, and R. van Heyningen Drugs, including alcohol, that act as risk factors for cataract, and possible protection against cataract by aspirin-like analgesics and cyclopenthiazide Br J Ophthalmol 72 1988 809 814
57. S.E. Hankinson, J.M. Seddon, and G.A. Colditz A prospective study of aspirin use and cataract extraction in women Arch Ophthalmol 111 1993 503 508
58. E.Y. Chew, G.A. Williams, and T.C. Burton Aspirin effects on the development of cataracts in patients with diabetes mellitus Early treatment diabetic retinopathy study report 16 Arch Ophthalmol 110 1992 339 342
59. W.G. Christen, J.E. Manson, and R.J. Glynn Low-dose aspirin and risk of cataract and subtypes in a randomized trial of U.S. physicians Ophthalmic Epidemiol 5 1998 133 142
60. R.G. Cumming, and P. Mitchell Medications and cataract The Blue Mountains Eye Study Ophthalmology 105 1998 1751 1758
61. R. Klein, B.E. Klein, and T.Y. Wong The association of cataract and cataract surgery with the long-term incidence of age-related maculopathy: the Beaver Dam eye study Arch Ophthalmol 120 2002 1551 1558
62. R. Klein, B.E. Klein, Q. Wang, and S.E. Moss Is age-related maculopathy associated with cataracts? Arch Ophthalmol 112 1994 191 196
63. J.J. Wang, P.G. Mitchell, R.G. Cumming, and R. Lim Cataract and age-related maculopathy: the Blue Mountains Eye Study Ophthalmic Epidemiol 6 1999 317 326
64. A. Arnarsson, F. Jonasson, and H. Sasaki Risk factors for nuclear lens opacification: the Reykjavik Eye Study Dev Ophthalmol 35 2002 12 20